Veterans Affairs Medical Center Substance Use Disorders Program
-
Services:
- Buprenorphine used in Treatment
- Naltrexone used in Treatment
- General Hospital (including VA hospital)
- Hepatitis A (HAV) vaccination
- Hepatitis B (HBV) vaccination
- Federal Government
- U.S. Department of Veterans Affairs
- Payment assistance (check with facility for details)
- This facility administers/prescribes medication for alcohol use disorder
- Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere
- Criminal justice (other than DUI/DWI)/Forensic clients
- Lesbian, gay, bisexual, transgender, or queer/questioning (LGBTQ)
- Clients with co-occurring pain and substance use disorders
- Clients who have experienced intimate partner violence, domestic violence
- Veterans
- Clients with co-occurring mental and substance use disorders
- Adult men
- Clients who have experienced sexual abuse
- Clients who have experienced trauma
- Clients with HIV or AIDS
- Adult women
- Seniors or older adults
- Active duty military
- Marital/couples counseling
- HIV or AIDS education, counseling, or support
- Hepatitis education, counseling, or support
- Individual counseling
- Group counseling
- Vocational training or educational support (for example, high school coursework, GED preparation, etc.)
- Smoking/vaping/tobacco cessation counseling
- Substance use disorder education
- Family counseling
- Health education services other than HIV/AIDS or hepatitis
- Vaping not permitted
- Aftercare/continuing care
- Discharge Planning
- Outcome follow-up after discharge
- Naloxone and overdose education
- Smoking not permitted
- Social skills development
- Early intervention for HIV
- Suicide prevention services
- Domestic violence services, including family or partner
- Integrated primary care services
- Acupuncture
- Case management service
- Mental health services
- Transportation assistance
- Prescribes naltrexone
- Accepts clients using MAT but prescribed elsewhere
- Prescribes buprenorphine
- Hospital inpatient detoxification
- Outpatient methadone/buprenorphine or naltrexone treatment
- Regular outpatient treatment
- Hospital inpatient treatment
- Outpatient
- Long-term residential
- Hospital inpatient/24-hour hospital inpatient
- Residential/24-hour residential
- Adults
- Young Adults
- Seniors
- Commission on Accreditation of Rehabilitation Facilities (CARF)
- Drug Enforcement Agency (DEA)
- The Joint Commission
- Substance use treatment
- Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
- Detoxification
- Female
- Male
- State-financed health insurance plan other than Medicaid
- Medicaid
- Federal, or any government funding for substance use treatment programs
- IHS/Tribal/Urban (ITU) funds
- Medicare
- Private health insurance
- Cash or self-payment
- Federal military insurance (e.g., TRICARE)
- Treatment for other addiction disorder
- Treatment for gambling disorder
- Medication routinely used during detoxification
- Benzodiazepines Detoxification
- Alcohol Detoxification
- Methamphetamines detoxification
- Cocaine Detoxification
- Opioids detoxification
- Trauma-related counseling
- Motivational interviewing
- Matrix Model
- Cognitive behavioral therapy
- 12-step facilitation
- Relapse prevention
- Anger management
- Community reinforcement plus vouchers
- Telemedicine/telehealth therapy
- Substance use disorder counseling
- Contingency management/motivational incentives
- Brief intervention
- Self-help groups
- Housing services
- Assistance with obtaining social services
- Mentoring/peer support
- Recovery coach
- Employment counseling or training
- Medications for Hepatitis C treatment
- Clonidine
- Buprenorphine with naloxone
- Medication for mental disorders
- Naltrexone (oral)
- Buprenorphine sub-dermal implant
- Buprenorphine (extended-release, injectable)
- Non-nicotine smoking/tobacco cessation
- Disulfiram
- Buprenorphine without naloxone
- Naltrexone (extended-release, injectable)
- Nicotine replacement
- Acamprosate (Campral®)
- Medications for HIV treatment
- Comprehensive substance use assessment
- Complete medical history/physical exam
- Interim services for clients
- Screening for mental disorders
- Outreach to persons in the community
- Screening for substance use
- Comprehensive mental health assessment
- Screening for tobacco use
- Drug and alcohol oral fluid testing
- Testing for Hepatitis C (HCV)
- Drug or alcohol urine screening
- STD testing
- Testing for Hepatitis B (HBV)
- TB screening
- Metabolic syndrome monitoring
- Breathalyzer or blood alcohol testing
- HIV testing
- Other contracted prescribing entity
- In-network prescribing entity
- In-network prescribing entity
- Other contracted prescribing entity
Opioid Medications used in Treatment
Hospitals
Medical Services
Facility Operation (e.g., Private, Public)
Payment Assistance Available
Type of Alcohol Use Disorder Treatment
Special Programs/Groups Offered
Education and Counseling Services
Facility Vaping Policy
Transitional Services
Facility Smoking Policy
Ancillary Services
Type of Opioid Treatment
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Age Groups Accepted
License/Certification/Accreditation
Type of Care
Gender Accepted
Payment/Insurance/Funding Accepted
Other Services
Detoxification (medical withdrawal) Services
Treatment Approaches
Recovery Support Services
Pharmacotherapies
Assessment/Pre-treatment
Testing
External Source of Medications Used for Alcohol Use Disorder Treatment
External Opioid Medications Source